12/03/24View in Browser
Welcome to Euractiv's weekly Health newsletter bringing you the latest news from across Europe on the subject of Health.
Ad

Dive into EU Elections 2024 with us

Don't miss a single update on the EU 2024 Elections – subscribe now to EU Elections Decoded for in-depth analysis and tracking of each party's moves.

Subscribe now >> .
 Latest News
Macron defends strict conditions of ‘French-style’ model for assisted dying on 11/03/24
A 'French-style' bill on assisted dying will be presented to France's Council of Ministers in April, President Emmanuel Macron confirmed in an interview on Sunday (10 March), underlining that it will function differently to similar laws in other EU countries.
Prioritizing Brain Health in the European Union: Closing the Treatment Gap [Promoted content] on 11/03/24
Angelini Pharma's CSO Rafal Kaminski, underscores the rising burden of brain diseases, advocating global attention to brain health. The Headway initiative is presented as a collaborative platform promoting harmonization programs and European guidelines, emphasizing science's crucial role in evidence-based decision-making.
Swedish opposition critical of government efforts to limit hospital layoffs [Advocacy Lab Content] on 10/03/24
In a bid to stem massive layoffs in Sweden’s emergency hospitals, the Swedish government wants to allocate an extra €530 million to the health sector. But the opposition and Swedens regions say it's not enough.
Bulgarians exposed to rare diseases health risks by bureaucracy [Advocacy Lab Content] on 10/03/24
Bulgaria's lack of a comprehensive strategy for rare diseases now poses a serious risk to patient health. Insufficient screening has left Bulgarians with rare diseases diagnosed late, or not at all, while fewer orphan drugs are available on average.
Belgian MEP proposes custom orphan drug exclusivity for innovation in untreated areas [Advocacy Lab Content] on 10/03/24
Belgian MEP Frederique Ries has proposed tailoring market exclusivity periods for orphan drugs to foster innovation, advocating a 12-year exclusivity period for orphan drug indications lacking authorised medicinal products in the EU.
French banks keep financing tobacco industry, despite promises on 07/03/24
Since 2018, French banks have granted more than five billion dollars in loans to the tobacco industry, according to a report by the investigative organisation Profundo, commissioned by the French Alliance Against Tobacco (ACT) and published on Wednesday (6 March).
Sharp rise in sexually transmitted infections in Europe, warns EU health agency on 07/03/24
The European Centre for Disease Prevention and Control (ECDC) warned that there is a need for action to address the significant rise in sexually transmitted infections (STIs) in the EU/EEA.
Opioids on the rise, under close surveillance in Europe on 06/03/24
In a report published on Tuesday (5 March), the International Narcotics Control Board (INCB) warned of the ever-increasing availability of drugs in Europe, voicing fears of an opioid crisis on the continent.
France enshrines abortion in its Constitution, a world first on 05/03/24
France has become the first country in the world to enshrine the right of women to have an abortion in the constitution, following a vote from MPs and senators who met in Congress at the Château de Versailles on Monday.
Poland struggles to accelerate efforts for a rare disease plan [Advocacy Lab Content] on 04/03/24
Poland adopted a National Rare Diseases Plan in 2021 - by December 2023, it had lapsed. New efforts are underway to push for a sustainable plan, but an exact date for resuming the Polish Rare Diseases Plan remains undisclosed.

Ad

BIOS24

The Medicines for Europe’s Biosimilar Medicines Conference is the occasion to accelerate biosimilar medicine development and equitable access. Experts will convene to discuss evolving landscapes and set collective aims for transformative healthcare. Taking place in Amsterdam, 18-19 April.

Join us >> .
 Health Weekly 
Slovakia trailing EU on rare disease treatment access [Advocacy Lab Content] (04/03/24)
Swedes get cancer diagnosis every seven minutes, new cancer plan needed [Advocacy Lab Content] (04/03/24)
Orphan therapies need common EU approach, says Czech patient group [Advocacy Lab Content] (04/03/24)
French Senate’s OK on abortion a defeat for the ‘anti-choice’ movement, says expert (01/03/24)
There is no drink of moderation, but only the practice of moderation [Promoted content] (29/02/24)
25th Rare Disease Day – a year of opportunity for life-changing therapies [Promoted content] (29/02/24)
Right here, right now European public health policies must start giving people living with rare diseases a fair chance [Promoted content] (29/02/24)
French Senate approves enshrining abortion in Constitution in historic vote (29/02/24)
Doctors in Europe divided over cannabis legalisation in Germany (28/02/24)
Health brief: Keeping antimicrobial resistance high on the agenda (28/02/24)
Europe needs new 360 rare diseases strategy [Advocacy Lab Content] (28/02/24)
Bulgaria halts €50 billion healthcare investment strategy until 2030 [Advocacy Lab Content] (28/02/24)
New rare diseases action plan on horizon, Europe at turning point [Advocacy Lab Content] (27/02/24)
Poland trailing in last place for contraception access [Advocacy Lab Content] (26/02/24)
Belgium’s biotech sector confronts access challenges beyond rare diseases [Advocacy Lab Content] (26/02/24)
Greece finally gets a National Cancer Registry, enhancing disease pathway monitoring [Advocacy Lab Content] (23/02/24)
Germany adopts controversial law to legalise cannabis (23/02/24)
Ukrainian refugee situation must stay ‘high’ on political agenda, WHO warns (23/02/24)
Czech shadow rapporteur weighs contentious new pharma package proposals [Advocacy Lab Content] (22/02/24)
Climate change’s invisible threats for mental health (21/02/24)
EU deal on improved air quality fails to align with WHO standards (21/02/24)
EU disease control centre picks Austrian centre-left lawmaker for top job (21/02/24)
From Luxembourg to Poland: an unequal landscape in contraception (21/02/24)
New Swedish rare diseases strategy commissioned [Advocacy Lab Content] (21/02/24)
Poland to promote new health education programme in schools [Advocacy Lab Content] (21/02/24)
Open the bottlenecks, centralise ATMP coordination, say Dutch researchers [Advocacy Lab Content] (20/02/24)
Pharma package, Swedish MEPs split ahead of ENVI vote [Advocacy Lab Content] (20/02/24)
No new cancer plan for Belgium, Vandenbroucke rejects calls for strategy change [Advocacy Lab Content] (20/02/24)
Cancer care inequalities rage across the EU, says Swedish Institute [Advocacy Lab Content] (20/02/24)
Why a successful transplant is only half the patient journey [Promoted content] (16/02/24)
France to discuss assisted dying bill before summer (15/02/24)
EU Disability Card goes some way to improving accessibility across the bloc (15/02/24)
Limiting competition in medicines is not an option (15/02/24)
Athens launches first Greek language rare diseases list [Advocacy Lab Content] (14/02/24)
The future of snus in Europe [Advocacy Lab Content] (14/02/24)
Next Commission will make ‘political’ decisions on tobacco directive, EU official says (14/02/24)
Malnutrition risk for two thirds of Slovak hospital patients (14/02/24)
Irish hospital researchers discover new AMR bacteria (14/02/24)
Health Brief: The health workforce has no time to lose (14/02/24)
Belgian EU presidency wants concrete action in future health workforce strategy (14/02/24)

No RSS items found.
Twitter
Instagram
Facebook
Website
LinkedIn
Spotify
YouTube
Euractiv Media Network BV: International Press Center Boulevard Charlemagne 1, Brussels, 1041 Belgium

Feedback    Update your preferences    Unsubscribe from ALL emails from us    Health hub